Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI (MRS)

This study has been completed.
Sponsor:
Collaborator:
University of Miami
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00561782
First received: November 19, 2007
Last updated: September 16, 2014
Last verified: September 2014